IART

Integra LifeSciences Holdings Corporation

Healthcare

$13.21

as of 16 Oct 2026, 36% below its 52-week high

Screens as less well placed to keep growing its dividend, though its cut-risk signals are low.

These scores are a resilience check on the dividend, not a recommendation to buy or sell. They are not financial advice.

Trailing yield: No dividend
Cash cover: No dividend
Earnings cover: No dividend
5y dividend growth: No dividend

Quality

Low

Capacity to keep growing the dividend

Risk

Low

Signals of dividend-cut pressure

Trim

Low

How extended the valuation looks

Why Quality is 36

Valuation against its own history

As of the last reported period (30 Jun 2026). P80 means the figure is higher than 80% of IART’s past readings.

P/E74.8×P92, poor for this measure
Yield0.0%P50, neutral for this measure
FCF payout0.0%P50, neutral for this measure
Net debt / EBITDA27.71P33, neutral for this measure
ROIC0.6%P91, good for this measure

Open valuation history

Forecast your income with the IART dividend calculator

Inspect surfaces history; it does not predict the future. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.